A Phase 1 Study to Assess the Safety and Tolerability of Multiple Ascending Doses of LB-P6 and LB-P8 in Healthy Participants

Conditions:   Rheumatoid Arthritis;   Non-Alcoholic Steatohepatitis Interventions:   Drug: LB-P6, Cohort 1;   Drug: LB-P8, Cohort 1;   Drug: Placebo, Cohort 1;   Drug: LB-P6, Cohort 2;   Drug: LB-P8, Cohort 2;   Drug: Placebo, Cohort 2 Sponsors:   LISCure Biosciences AUS Pty LTD;   Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials